R S Shulman

669 total citations
16 papers, 504 citations indexed

About

R S Shulman is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, R S Shulman has authored 16 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in R S Shulman's work include Cardiac Imaging and Diagnostics (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Blood Pressure and Hypertension Studies (3 papers). R S Shulman is often cited by papers focused on Cardiac Imaging and Diagnostics (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Blood Pressure and Hypertension Studies (3 papers). R S Shulman collaborates with scholars based in United States and Russia. R S Shulman's co-authors include Peter N. Herbert, Donald S. Fredrickson, Julie A. Patterson, B. F. Hurley, M. A. Smutok, Christine Reece, Peter Kokkinos, Charles M. Farmer, Percy M. Dawson and A K Bhattacharyya and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

R S Shulman

14 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R S Shulman United States	9	147	144	135	128	118	16	504
Yining Yang China	13	80 0.5×	169 1.2×	83 0.6×	65 0.5×	64 0.5×	48	570
B A Leatherdale United Kingdom	18	120 0.8×	219 1.5×	462 3.4×	109 0.9×	41 0.3×	34	900
Tine Lovsø Dohlmann Denmark	13	75 0.5×	99 0.7×	42 0.3×	222 1.7×	101 0.9×	19	509
Kirsti Hällsten Finland	15	159 1.1×	191 1.3×	310 2.3×	373 2.9×	40 0.3×	18	963
Yoshitada Yajima Japan	12	54 0.4×	52 0.4×	239 1.8×	74 0.6×	34 0.3×	28	504
Katia Bonomo Italy	12	240 1.6×	209 1.5×	693 5.1×	222 1.7×	64 0.5×	17	1.1k
Nagako Kitagawa Japan	9	71 0.5×	73 0.5×	171 1.3×	260 2.0×	18 0.2×	12	669
Aled Roberts United Kingdom	8	88 0.6×	70 0.5×	67 0.5×	83 0.6×	23 0.2×	11	317
D. Vallance United Kingdom	10	178 1.2×	287 2.0×	195 1.4×	87 0.7×	17 0.1×	16	532
Shohei Ouchi Japan	14	105 0.7×	104 0.7×	50 0.4×	83 0.6×	24 0.2×	40	457

Countries citing papers authored by R S Shulman

Since Specialization

Citations

This map shows the geographic impact of R S Shulman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R S Shulman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R S Shulman more than expected).

Fields of papers citing papers by R S Shulman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R S Shulman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R S Shulman. The network helps show where R S Shulman may publish in the future.

Co-authorship network of co-authors of R S Shulman

This figure shows the co-authorship network connecting the top 25 collaborators of R S Shulman. A scholar is included among the top collaborators of R S Shulman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R S Shulman. R S Shulman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Shulman, R S, Wei Yang, Peter P. Reese, et al.. (2025). Renin-Angiotensin System Inhibitors in Patients With Nonproteinuric Chronic Kidney Disease and Kidney Outcomes: Findings From the CRIC Study. Kidney Medicine. 8(1). 101159–101159.

Shulman, R S, et al.. (2024). Cardiac Effects of Renin-Angiotensin System Inhibitors in Nonproteinuric CKD. Hypertension. 81(10). 2082–2090. 1 indexed citations

Shulman, R S, et al.. (2024). Cardiovascular and Kidney Outcomes of Non-Diabetic CKD by Albuminuria Severity: Findings From the CRIC Study. American Journal of Kidney Diseases. 84(6). 742–750.e1. 2 indexed citations

Smutok, M. A., Christine Reece, Peter Kokkinos, et al.. (1993). Aerobic versus strength training for risk factor intervention in middle-aged men at high risk for coronary heart disease. Metabolism. 42(2). 177–184. 145 indexed citations

Kokkinos, Peter, B. F. Hurley, M. A. Smutok, et al.. (1991). Strength training does not improve lipoprotein-lipid profiles in men at risk for CHD. Medicine & Science in Sports & Exercise. 23(10). 1134???1139–1134???1139. 55 indexed citations

Bhattacharyya, A K, et al.. (1991). Sluggish sitosterol turnover and hepatic failure to excrete sitosterol into bile cause expansion of body pool of sitosterol in patients with sitosterolemia and xanthomatosis.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 11(5). 1287–1294. 72 indexed citations

Smutok, M. A., Christine Reece, A. P. Goldberg, et al.. (1989). STRENGTH TRAINING IMPROVES GLUCOSE TOLERANCE SIMILAR TO THAT OF JOGGING IN MIDDLE-AGED MEN. Medicine & Science in Sports & Exercise. 21(Supplement). S33–S33. 4 indexed citations

Boden, William E., Edward W. Bough, Melvin Reichman, et al.. (1985). Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.. Circulation. 71(6). 1197–1205. 47 indexed citations

Shulman, R S, Peter N. Herbert, Robert J. Capone, et al.. (1983). Effects of propranolol on blood lipids and lipoproteins in myocardial infarction.. PubMed. 67(6 Pt 2). I19–21. 19 indexed citations

10.

Gandsman, Elan J., R S Shulman, Ian Tyson, & Edward W. Bough. (1982). Calculation of the left ventricular ejection fraction by gated radionuclide angiography without direct background correction.. Radiology. 144(2). 377–381. 3 indexed citations

11.

Gandsman, Elan J., et al.. (1981). Measurement of the ventricular stroke volume ratio by gated radionuclide angiography.. Radiology. 138(1). 161–165. 12 indexed citations

12.

Henderson, L. Omar, et al.. (1980). Minimal within-day variation of high density lipoprotein cholesterol and apolipoprotein A-I levels in normal subjects. Journal of Lipid Research. 21(7). 953–955. 18 indexed citations

13.

Kokkinos, Peter, B. F. Hurley, M. A. Smutok, et al.. (1980). LIPOPROTEIN-LIPID PROFILES AND POST-HEPARIN LIPASE ACTIVITIES ARE UNALTERED FROM STRENGTH TRAINING. Medicine & Science in Sports & Exercise. 21(Supplement). S116–S116. 1 indexed citations

14.

Smutok, M. A., Christine Reece, Andrew P. Goldberg, et al.. (1980). STRENGTH TRAINING IMPROVES GLUCOSE TOLERANCE SIMILAR TO THAT OF JOGGING IN MIDDLE-AGED MEN. Medicine & Science in Sports & Exercise. 21(Supplement). S33–S33. 6 indexed citations

15.

Herbert, Peter N., et al.. (1977). Lipoprotein lipase cofactor activity of a carboxyl-terminal peptide of apolipoprotein C-II.. Proceedings of the National Academy of Sciences. 74(12). 5358–5362. 24 indexed citations

16.

Shulman, R S, et al.. (1975). Thf complete amino acid sequence of C-I (apoLp-Ser), an apolipoprotein from human very low density lipoproteins.. Journal of Biological Chemistry. 250(1). 182–190. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact